| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824815 | Clinical Therapeutics | 2015 | 8 Pages |
Abstract
Similar median PFS point estimates and overlapping CIs suggest that everolimus and axitinib have similar efficacy. Although these results do not negate the need for direct comparison, this study may be used to inform clinical and reimbursement decisions until such evidence is available.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Steven MPH, Billy MSc, MPA, PhD, Emiliano MD, PhD, Xufang MD, MBA, Jinhee PhD, Zhimei PhD, Chinjune MD, Roman MSc,